Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Fuji
Accenture
Healthtrust
UBS
Cantor Fitzgerald
Cipla
Citi
Federal Trade Commission

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206538

« Back to Dashboard

NDA 206538 describes TOUJEO SOLOSTAR, which is a drug marketed by Sanofi Us Services and is included in one NDA. It is available from one supplier. There are nineteen patents protecting this drug. Additional details are available on the TOUJEO SOLOSTAR profile page.

The generic ingredient in TOUJEO SOLOSTAR is insulin glargine recombinant. There are thirty-nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the insulin glargine recombinant profile page.
Summary for 206538
Tradename:TOUJEO SOLOSTAR
Applicant:Sanofi Us Services
Ingredient:insulin glargine recombinant
Patents:20
Pharmacology for NDA: 206538
Ingredient-typeInsulin
Suppliers and Packaging for NDA: 206538
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TOUJEO MAX SOLOSTAR insulin glargine recombinant SOLUTION;SUBCUTANEOUS 206538 NDA Sanofi-Aventis U.S. LLC 0024-5869 N 0024-5869-00
TOUJEO SOLOSTAR insulin glargine recombinant SOLUTION;SUBCUTANEOUS 206538 NDA Sanofi-Aventis U.S. LLC 0024-5869 N 0024-5869-00

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;SUBCUTANEOUSStrength450 UNITS/1.5ML (300 UNITS/ML)
Approval Date:Feb 25, 2015TE:RLD:Yes
Regulatory Exclusivity Expiration:Feb 25, 2018
Regulatory Exclusivity Use:NEW PRODUCT
Patent:➤ Sign UpPatent Expiration:Mar 23, 2028Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Sign UpPatent Expiration:Sep 15, 2024Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Cipla
Baxter
Boehringer Ingelheim
Healthtrust
UBS
Queensland Health
QuintilesIMS
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.